FONAR Corporation
FONAR Corporation (FONR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fonr · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
FONAR CorporationYou FONR | $118M | 17.60x | — | $1.08 |
 Apyx Medical Corporation APYX | $200M | N/A | — | -$0.27 |
 Artiva Biotherapeutics, Inc. ARTV | $168M | N/A | — | -$3.43 |
 Edap Tms S.a. EDAP | $178M | N/A | — | -$0.78 |
 Hyperfine, Inc. HYPR | $119M | N/A | — | -$0.38 |
 InflaRx N.V. IFRX | $124M | N/A | — | -$0.68 |
 Pulmonx Corporation LUNG | $63M | N/A | — | -$1.33 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for FONAR Corporation (FONR) measures how much investors pay for each dollar of the company's trailing earnings. FONR's current PE ratio of 17.60x is calculated by dividing its stock price of $19.09 by its TTM earnings per share of $1.08.
Frequently asked questions
FONR pe ratio · 6 questionsFONR's current PE ratio is 17.60x as of 2026-06-09, based on a stock price of $19.09 and TTM EPS of $1.08. Data sourced from Financial Modeling Prep via FONR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · FONAR Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09